Peter Grogg
Director/Board Member chez BACHEM HOLDING AG
Fortune : 4 116 M $ au 31/03/2024
Profil
Peter Grogg est président du conseil d'administration d'Ingro Finanz AG. Il est membre du conseil d'administration de Kenta Biotech AG et de Bachem Holding AG. Auparavant, le Dr Grogg a été employé en tant que vice-président du conseil de surveillance par Sunstar-Holding AG, vice-président par Dottikon Es Holding AG, directeur général par Bachem AG, associé par Fox-Chemicals GmbH, directeur par Ciba Holding AG, président par MFC Beteiligungs AG et président par Pevion Biotech AG. Il a également été membre du conseil d'administration de Berna Biotech AG, GABA AG et Polyphor AG.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
BACHEM HOLDING AG CLASS B
51,94% | 12/05/2023 | 38 957 455 ( 51,94% ) | 3 737 M $ | 31/03/2024 |
DOTTIKON ES HOLDING AG
7,00% | 31/03/2023 | 979 936 ( 7,00% ) | 259 M $ | 31/03/2024 |
BURKHALTER HOLDING AG
10,39% | 31/12/2022 | 1 103 787 ( 10,39% ) | 120 M $ | 31/03/2024 |
Postes actifs de Peter Grogg
Sociétés | Poste | Début |
---|---|---|
BACHEM HOLDING AG | Director/Board Member | - |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Director/Board Member | - |
Ingro Finanz AG
Ingro Finanz AG Financial ConglomeratesFinance Ingro Finanz AG provides investment services. The private company is based in Bubendorf, Switzerland. | Chairman | 05/01/2011 |
Anciens postes connus de Peter Grogg
Sociétés | Poste | Fin |
---|---|---|
DOTTIKON ES HOLDING AG | Director/Board Member | 06/07/2012 |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Chief Executive Officer | 01/01/2002 |
MFC Beteiligungs AG | Chairman | - |
Sunstar-Holding AG
Sunstar-Holding AG Hotels/Resorts/Cruise linesConsumer Services Sunstar-Holding AG engages in the operation of holiday hotels. The company was founded by Fritz Buser and Ernst Rieder on March 14, 1969 and is headquartered in Liestal, Switzerland. | Director/Board Member | - |
Fox-Chemicals GmbH | Corporate Officer/Principal | - |
Formation de Peter Grogg
University of Basel | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
BACHEM HOLDING AG | Health Technology |
SPEXIS AG | Health Technology |
Entreprise privées | 11 |
---|---|
Ciba Holding AG
Ciba Holding AG Chemicals: Major DiversifiedProcess Industries Ciba Holding AG manufactures and markets chemicals that provide color, performance and care for plastics, coatings, textile, paper, home & personal care and other products. The firm provides services to the plastic, rubber, adhesives lubricant, home and personal care, coatings, graphic arts, electronic, detergents and hygiene industries. It operates through four segments Plastic Additives, Coating Effects, Water & Paper Treatment and Textile Effects. The company has offices in Europe, America and Asia. Ciba Holding was founded on April 24, 1996 and is headquartered in Basel, Switzerland. | Process Industries |
Berna Biotech AG
Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland | Commercial Services |
Sunstar-Holding AG
Sunstar-Holding AG Hotels/Resorts/Cruise linesConsumer Services Sunstar-Holding AG engages in the operation of holiday hotels. The company was founded by Fritz Buser and Ernst Rieder on March 14, 1969 and is headquartered in Liestal, Switzerland. | Consumer Services |
Ingro Finanz AG
Ingro Finanz AG Financial ConglomeratesFinance Ingro Finanz AG provides investment services. The private company is based in Bubendorf, Switzerland. | Finance |
GABA AG
GABA AG Medical DistributorsDistribution Services GABA AG manufactures oral care products. Its brands include aronal, elmex and meridol. GABA develops its develops products in the field of dentistry, molecular biology, ergonomy, and others. The company was founded in 1917 by Dr. Hermann Geiger and is headquartered in Therwil, Switzerland. | Distribution Services |
Dottikon ES Holding AG | |
Pevion Biotech AG
Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Pevion Biotech AG develops efficient and safe vaccines based on proprietary technology. The firm provides preclinical and clinical development of prophylactic/therapeutic vaccines based on its virosome-based technology platform. The company was founded in 2002 and is headquartered in Ittigen, Switzerland. | Health Technology |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Fox-Chemicals GmbH | |
MFC Beteiligungs AG | |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |